Refractory T Acute Lymphoblastic Leukemia

specific

An acute lymphoblastic leukemia that does not respond to treatment.

33

Centers

35

Active Trials

Cancer Funding

Top Centers for Refractory T Acute Lymphoblastic Leukemia(33)

Ranked by research excellence score (trials · grants · publications). Methodology →

#CenterScore
1
High-Volume Research Center
72.7
2
High-Volume Research Center
72.7
3
NCI Comprehensive
Active Research Program
50.2
4
NCI Comprehensive
Active Research Program
50.2
5
NCI Comprehensive
Active Research Program
50.2
6
NCI Comprehensive
Active Research Program
50.2
7
NCI Comprehensive
Active Research Program
50.2
8
NCI Comprehensive
Active Research Program
50.2
9
NCI Comprehensive
Active Research Program
50.2
1050.2
11
Masonic Cancer CenterMinneapolis, MN
NCI Comprehensive
Active Research Program
50.2
12
NCI Comprehensive
Active Research Program
50.2
13
NCI Comprehensive
Active Research Program
50.2
14
NCI Comprehensive
Active Research Program
50.2
15
NCI Comprehensive
Active Research Program
50.2
16
NCI Comprehensive
Active Research Program
50.2
17
NCI Comprehensive
Active Research Program
50.2
18
Active Research Program
50.2
19
NCI Comprehensive
Active Research Program
50.2
20
Active Research Program
50.2
21
NCI Clinical
Active Research Program
50.2
22
NCI Comprehensive
Active Research Program
50.2
23
NCI Comprehensive
Active Research Program
50.2
24
Rutgers Cancer InstituteNew Brunswick, NJ
NCI Comprehensive
Active Research Program
50.2
25
NCI Comprehensive
Active Research Program
50.2
26
NCI Comprehensive
Active Research Program
50.2
2750.2
28
Active Research Program
50.2
29
Active Research Program
50.2
30
Active Research Program
50.2
31
Active Research Program
50.2
32
Active Research Program
50.2
33
Active Research Program
50.2

Research tier badges reflect trial volume, NIH grant funding, and publication impact — not clinical outcomes or patient satisfaction. Learn about our methodology →